Report Overview: The Global Genomics in Cancer Care Market achieved a valuation of $13.91 Billion in 2022 and is anticipated to exceed $45.27 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.9% during the forecast period from 2024 to 2032. Key Market Players: Agilent Technologies, Illumina, Inc., Pacific Biosciences, Inc., ThermoFisher Scientific Inc.,...